成人院外心脏骤停中静脉与肱骨骨内通路与患者结局的关联
该研究利用BC心脏骤停登记数据,纳入2112例成人院外心脏骤停,首次骤停期间血管通路由ALS培训的急救员尝试为静脉或肱骨骨内。采用倾向评分调整的逆概率治疗加权模型,比较两种通路与出院时良好神经结局(CPC 1-2)和生存的关联,并按初始心律分层。结果显示静脉首选与良好神经结局(AOR 1.7;95%CI 1.1-2.7)和生存(AOR 1.5;95%CI 1.0-2.3)改善相关;在可电击心律亚组中良好神经结局关联更强(AOR 4.2;95%CI 2.1-8.2),非可电击心律亚组无此关联(AOR 0.73;95%CI 0.39-1.4)。
要点
- 在2112例成人院外心脏骤停中,静脉首选较肱骨骨内首选与出院良好神经结局改善相关(AOR 1.7;95%CI 1.1-2.7)。
- 静脉首选较肱骨骨内首选与出院生存改善相关(AOR 1.5;95%CI 1.0-2.3)。
- 初始可电击心律亚组中,静脉首选与良好神经结局改善相关(AOR 4.2;95%CI 2.1-8.2)。
- 初始非可电击心律亚组中,静脉首选与良好神经结局无显著关联(AOR 0.73;95%CI 0.39-1.4)。
- 静脉组与骨内组从ALS急救员到达现场至血管通路时间(6.6 vs. 6.9 min)和至肾上腺素给药时间(9.0 vs. 9.3 min)相似。
适用人群与场景
- 成人院外心脏骤停,首次骤停期间血管通路由ALS培训的急救员尝试为静脉或肱骨骨内。
研究设计与关键结果
- 研究类型:基于BC心脏骤停登记数据的倾向评分调整模型(逆概率治疗加权)分析;共纳入2112例,静脉首选1575例,肱骨骨内首选537例。
- 静脉组与骨内组从ALS急救员到达现场至血管通路时间分别为6.6 min vs. 6.9 min,至肾上腺素给药时间分别为9.0 min vs. 9.3 min。
- 静脉组与骨内组分别有98例(6.2%)和20例(3.7%)出现良好神经结局(CPC 1-2)。
- 静脉首选较肱骨骨内首选与出院良好神经结局改善相关(AOR 1.7;95%CI 1.1-2.7)。
- 静脉首选较肱骨骨内首选与出院生存改善相关(AOR 1.5;95%CI 1.0-2.3)。
- 初始可电击心律亚组中,静脉首选与良好神经结局改善相关(AOR 4.2;95%CI 2.1-8.2)。
- 初始非可电击心律亚组中,静脉首选与良好神经结局无显著关联(AOR 0.73;95%CI 0.39-1.4)。
证据类型、等级与局限
- 证据类型:基于登记数据的观察性研究,采用倾向评分调整的逆概率治疗加权模型。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在骤停期间复苏中,与肱骨骨内通路相比,静脉首选通路与出院良好神经结局和生存的改善几率相关。
- 作者指出,该关联见于初始可电击心律亚组,但未见于此非可电击心律亚组。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: While intravenous (IV) vascular access for out-of-hospital cardiac arrest (OHCA) resuscitation is standard, humeral-intraosseous (IO) access is commonly used, despite few supporting data. We investigated the association between IV vs. humeral-IO and outcomes.
METHODS: We utilized BC Cardiac Arrest Registry data, including adult OHCA where the first-attempted intra-arrest vascular access route performed by advanced life support (ALS)-trained paramedics was IV or humeral-IO. We fit a propensity-score adjusted model with inverse probability treatment weighting to estimate the association between IV vs. humeral-IO routes and favorable neurological outcomes (CPC 1-2) and survival at hospital discharge. We repeated models within subgroups defined by initial cardiac rhythm.
RESULTS: We included 2,112 cases; the first-attempted route was IV (n = 1,575) or humeral-IO (n = 537). Time intervals from ALS-paramedic on-scene arrival to vascular access (6.6 vs. 6.9 min) and epinephrine administration (9.0 vs. 9.3 min) were similar between IV and IO groups, respectively. Among IV and humeral-IO groups, 98 (6.2%) and 20 (3.7%) had favorable neurological outcomes. Compared to humeral-IO, an IV-first approach was associated with improved hospital-discharge favorable neurological outcomes (AOR 1.7; 95% CI 1.1-2.7) and survival (AOR 1.5; 95% CI 1.0-2.3). Among shockable rhythm cases, an IV-first approach was associated with improved favorable neurological outcomes (AOR 4.2; 95% CI 2.1-8.2), but not among non-shockable rhythm cases (AOR 0.73; 95% CI 0.39-1.4).
CONCLUSION: An IV-first approach, compared to humeral-IO, for intra-arrest resuscitation was associated with an improved odds of favorable neurological outcomes and survival to hospital discharge. This association was seen among an initial shockable rhythm, but not non-shockable rhythm, subgroups.
参考来源
- Brebner C, Asamoah-Boaheng M, Zaidel B, et al. The association of intravenous vs. humeral-intraosseous vascular access with patient outcomes in adult out-of-hospital cardiac arrests. Resuscitation. 2024. PMID: 39154890. doi:10.1016/j.resuscitation.2024.110360
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。